Stiefel completes acquisition

Skin & Allergy News, Sept, 2008 by Alicia Ault

Stiefel Laboratories has completed its purchase of Barrier Therapeutics, a Princeton, N.J.-based company that has three topical products on the market, Xolegel, Vusion, and Solage. "Barrier's innovative products and pipeline are a very valuable addition to Stiefel," company CEO Charles W. Stiefel said in a statement.

With the purchase of Barrier, Stiefel adds a development portfolio that includes products for onychomycosis, psoriasis, acne, skin allergies, and acute fungal infections. The family-owned Stiefel claims to be the world's largest dermatologic specialty pharmaceutical company. It does not publicly report sales or earnings.

COPYRIGHT 2008 International Medical News Group
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale